Physiologically-based pharmacokinetic modeling for primary metabolites of CYP3A and P-glycoprotein inhibitors in drug-drug interactions: Should we assume the free drug hypothesis?
Shinji YamazakiRaymond EversLoeckie De ZwartPublished in: CPT: pharmacometrics & systems pharmacology (2022)